Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers

Abstract KCNH2 encodes the human ether-a-go-go-related gene (hERG) potassium channel and is an important repolarization reserve for regulating cardiac electrical activity. Increasing evidence suggests that it is involved in the development of various tumours, yet a thorough analysis of the underlyin...

Full description

Bibliographic Details
Main Authors: Zequn Zheng, Yongfei Song
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Bioinformatics
Subjects:
Online Access:https://doi.org/10.1186/s12859-023-05180-9
_version_ 1797863322465337344
author Zequn Zheng
Yongfei Song
author_facet Zequn Zheng
Yongfei Song
author_sort Zequn Zheng
collection DOAJ
description Abstract KCNH2 encodes the human ether-a-go-go-related gene (hERG) potassium channel and is an important repolarization reserve for regulating cardiac electrical activity. Increasing evidence suggests that it is involved in the development of various tumours, yet a thorough analysis of the underlying process has not been performed. Here, we have comprehensively examined the role of KCNH2 in multiple cancers by assessing KCNH2 gene expression, diagnostic and prognostic value, genetic alterations, immune infiltration correlations, RNA modifications, mutations, clinical correlations, interacting proteins, and associated signalling pathways. KCNH2 is differentially expressed in over 30 cancers and has a high diagnostic value for 10 tumours. Survival analysis showed that high expression of KCNH2 was associated with a poor prognosis in glioblastoma multiforme (GBM) and hepatocellular carcinoma (LIHC). Mutations and RNA methylation modifications (especially m6A) of KCNH2 are associated with its expression in multiple tumours. KCNH2 expression is correlated with tumour mutation burden, microsatellite instability, neoantigen load, and mutant-allele tumour heterogeneity. In addition, KCNH2 expression is associated with the tumour immune microenvironment and its immunosuppressive phenotype. KEGG signalling pathway enrichment analysis revealed that KCNH2 and its interacting molecules are involved in a variety of pathways related to carcinogenesis and signal regulation, such as the PI3K/Akt and focal adhesion pathways. Overall, we found that KCNH2 and its interaction molecular are expected to be immune-related biomarkers for cancer diagnosis and prognosis evaluation, and are potential regulatory targets of singalling pathways for tumour development due to their significant role in cancers.
first_indexed 2024-04-09T22:34:49Z
format Article
id doaj.art-4a941101ffd34b39820000eed41f2ced
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-04-09T22:34:49Z
publishDate 2023-02-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-4a941101ffd34b39820000eed41f2ced2023-03-22T12:33:18ZengBMCBMC Bioinformatics1471-21052023-02-0124111610.1186/s12859-023-05180-9Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancersZequn Zheng0Yongfei Song1Department of Cardiovascular Medicine, First Affiliated Hospital of Shantou University Medical College, Shantou UniversityNingbo Institute of Innovation for Combined Medicine and Engineering, Lihuili Hospital Affiliated to Ningbo UniversityAbstract KCNH2 encodes the human ether-a-go-go-related gene (hERG) potassium channel and is an important repolarization reserve for regulating cardiac electrical activity. Increasing evidence suggests that it is involved in the development of various tumours, yet a thorough analysis of the underlying process has not been performed. Here, we have comprehensively examined the role of KCNH2 in multiple cancers by assessing KCNH2 gene expression, diagnostic and prognostic value, genetic alterations, immune infiltration correlations, RNA modifications, mutations, clinical correlations, interacting proteins, and associated signalling pathways. KCNH2 is differentially expressed in over 30 cancers and has a high diagnostic value for 10 tumours. Survival analysis showed that high expression of KCNH2 was associated with a poor prognosis in glioblastoma multiforme (GBM) and hepatocellular carcinoma (LIHC). Mutations and RNA methylation modifications (especially m6A) of KCNH2 are associated with its expression in multiple tumours. KCNH2 expression is correlated with tumour mutation burden, microsatellite instability, neoantigen load, and mutant-allele tumour heterogeneity. In addition, KCNH2 expression is associated with the tumour immune microenvironment and its immunosuppressive phenotype. KEGG signalling pathway enrichment analysis revealed that KCNH2 and its interacting molecules are involved in a variety of pathways related to carcinogenesis and signal regulation, such as the PI3K/Akt and focal adhesion pathways. Overall, we found that KCNH2 and its interaction molecular are expected to be immune-related biomarkers for cancer diagnosis and prognosis evaluation, and are potential regulatory targets of singalling pathways for tumour development due to their significant role in cancers.https://doi.org/10.1186/s12859-023-05180-9KCNH2PancancerDiagnosisPrognosisRNA modificationImmunoassay
spellingShingle Zequn Zheng
Yongfei Song
Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers
BMC Bioinformatics
KCNH2
Pancancer
Diagnosis
Prognosis
RNA modification
Immunoassay
title Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers
title_full Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers
title_fullStr Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers
title_full_unstemmed Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers
title_short Integrated analysis of the voltage-gated potassium channel-associated gene KCNH2 across cancers
title_sort integrated analysis of the voltage gated potassium channel associated gene kcnh2 across cancers
topic KCNH2
Pancancer
Diagnosis
Prognosis
RNA modification
Immunoassay
url https://doi.org/10.1186/s12859-023-05180-9
work_keys_str_mv AT zequnzheng integratedanalysisofthevoltagegatedpotassiumchannelassociatedgenekcnh2acrosscancers
AT yongfeisong integratedanalysisofthevoltagegatedpotassiumchannelassociatedgenekcnh2acrosscancers